Stay updated with breaking news from Data featured. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
phData, Inc.: phData Featured at Snowflake Summit 2023 as an Elite Partner finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
YPF y su Fundación entregaron 584 notebooks para estudiantes de escuelas técnicas secundarias lanoticia1.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lanoticia1.com Daily Mail and Mail on Sunday newspapers.
Published: May 11, 2021 - Enrollment Now Underway in Multiple Solid Tumor and Hematologic Malignancy Expansion Cohorts in Phase 1 Trial of Oral PRMT5 Inhibitor PRT543 - - Initial Clinical Data Readouts for Lead Oral PRMT5 Inhibitors PRT543 and PRT811 Expected in 2H21 - - Dose Escalation Ongoing in Phase 1 Trial of Oral MCL1 Inhibitor PRT1419, with Dose Expansion Cohorts on Track to be Added in 2H21 - WILMINGTON, Del., May 11, 2021 (GLOBE NEWSWIRE) Prelude Therapeutics Inc. (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced its financial results for the first quarter ended March 31, 2021 and provided an update on recent clinical and development pipeline progress. ....